Bilateral
9 Mar 2016
Kidney cancer news
17 Apr 2024
Cancer52 manifesto launch
12 Apr 2024
Immunotherapy combinations versus TKIs for papillary renal cell carcinoma
9 Apr 2024
CAR T cell immunotherapy shows promise for patients with kidney cancer
9 Apr 2024
Real world data on the use of cabozantinib plus immunotherapy in the second line
25 Mar 2024
How to manage anxiety and depression when you have kidney cancer
12 Mar 2024
Immunotherapy improves survival in kidney cancer patients with brain metastases
8 Mar 2024
Radiotherapy for the management of renal medullary carcinoma
8 Mar 2024
Manchester patient focus group
8 Mar 2024
NICE approves cabozantinib plus nivolumab for advanced kidney cancer
15 Feb 2024
PRISM study highlights possibility of reducing dose of immunotherapy
15 Feb 2024
World-class radiotherapy in the UK
7 Feb 2024
Summary of kidney cancer highlights from ASCO GU 2024
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo sunitinib Sutent cabozantinib progression-free survival NHS England biomarkers ipilimumab Cabometyx pembrolizumab COVID-19 axitinib cancer survival non-clear cell kidney cancer VEGF inhibitors Inlyta coronavirus kidney cancer Yervoy risk factors Keytruda adjuvant therapy metastases targeted therapy papillary RCC biological markers everolimus Afinitor cancer outcomes ASCO first-line treatment NICEArchives
- 2024: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
